Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Flagship Biosciences provides advanced spatial biology and biomarker analytics services using proprietary AI-powered digital pathology platforms. The company supports pharmaceutical and biotech clients from preclinical through commercialization with tissue-based analytics that improve the accuracy of biomarker discovery and patient stratification. Their acquisition of Interpace Pharma Solutions expanded their capabilities into cytogenetics and molecular profiling. They do not develop their own therapeutics but enable drug development programs with high-quality data science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Flagship Biosciences.